UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

In Vitro Activities of the Potent, Broad-Spectrum Carbapenem MK-0826 (L-749,345) against Broad-Spectrum β-Lactamase-and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli Clinical Isolates

Antimicrobial Agents and Chemotherapy, 1999-05, Vol.43 (5), p.1170-1176

1999

Volltextzugriff (PDF)

In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)

Antimicrobial Agents and Chemotherapy, 1998-08, Vol.42 (8), p.1996-2001

1998

Volltextzugriff (PDF)

Carbapenems, a new class of beta-lactam antibiotics

The American journal of medicine, 1985-06, Vol.78 (6), p.3-21

1985

Volltextzugriff (PDF)

Reduced Immunotoxicity and Preservation of Antibacterial Activity in a Releasable Side-Chain Carbapenem Antibiotic

Science (American Association for the Advancement of Science), 1999-01, Vol.283 (5402), p.703-706

1999

Volltextzugriff (PDF)

Effects of Antibiotic Therapy on Pseudomonas aeruginosa-Induced Lung Injury in a Rat Model

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2389-2394

1999

Volltextzugriff (PDF)

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

Antimicrobial Agents and Chemotherapy, 1982-07, Vol.22 (1), p.62-70

1982

Volltextzugriff (PDF)

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Antimicrobial Agents and Chemotherapy, 1997-11, Vol.41 (11), p.2333-2338

1997

Volltextzugriff (PDF)

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Antimicrobial Agents and Chemotherapy, 1997-11, Vol.41 (11), p.2339-2344

1997

Volltextzugriff (PDF)

beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime

The Journal of infectious diseases, 1992-06, Vol.165 (6), p.1033

1992

Volltextzugriff (PDF)

THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)

Annals of the New York Academy of Sciences, 1974-05, Vol.235 (1), p.364-386

1974

Volltextzugriff (PDF)

In Vivo Evaluation of Three Acid-stable Azalide Compounds, L-701, 677, L-708, 299 and L-708, 365 Compared to Erythromycin, Azithromycin and Clarithromycin

The Journal of Antibiotics, 1995/10/25, Vol.48(10), pp.1141-1147

1995

Volltextzugriff (PDF)

Reduced immunotoxicity and preservation of antibacterial acitivity in a releasable side-chain carbapenem antibiotic

Science (American Association for the Advancement of Science), 1999-01, Vol.283 (5402), p.703-706

1999

Volltextzugriff (PDF)

Carbapenems, a new class of beta-lactam antibiotics: Discovery and development of imipenem/cilastatin

The American journal of medicine, 1985-06, Vol.78 (6), p.3-21

1985

Volltextzugriff (PDF)

Differences in mode of action of (β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy

Journal of Endotoxin Research [J. ENDOTOXIN RES.]. Vol. 3, no. 3. 1996, 1996, Vol.3 (3), p.201-218

1996

Volltextzugriff (PDF)

Thienamycin: development of imipenem-cilastatin

Journal of antimicrobial chemotherapy, 1983, Vol.12 (suppl-D), p.1-35

1983

Volltextzugriff (PDF)

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)

Journal of medicinal chemistry, 1992-01, Vol.35 (1), p.194-198

1992

Volltextzugriff (PDF)

The discovery and synthesis of 2-biphenylcarbapenems active against methicillin resistant staphylococci

Bioorganic & medicinal chemistry letters, 1995-05, Vol.5 (9), p.945-948

1995

Volltextzugriff (PDF)

Cephamycins, a New Family of β-Lactam Antibiotics. IV. In Vivo Studies

Antimicrobial Agents and Chemotherapy, 1972-10, Vol.2 (4), p.287-290

1972

Volltextzugriff (PDF)

Influence of antibiotic class and concentration on the percentage of release of lipopolysaccharide from Escherichia coli

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.471

1994

Volltextzugriff (PDF)

Beta-lactam antibiotic-induced release of free lipopolysaccharide

The Journal of infectious diseases, 1993-03, Vol.167 (3), p.775

Hurley, J C

1993

Volltextzugriff (PDF)

Antibacterial Activity of Imipenem: The First Thienamycin Antibiotic

Reviews of infectious diseases, 1985-07, Vol.7, p.S389-S410

1985

Volltextzugriff (PDF)

Cephamycins, a New Family of β-Lactam Antibiotics. IV. In Vivo Studies1

Antimicrobial agents and chemotherapy, 1972-10, Vol.2 (4), p.287-290

1972

Volltextzugriff (PDF)

Modulation of Immune Responses by Platelet-Derived ADAM10

Frontiers in immunology, 2020-02, Vol.11, p.44-44

2020

Volltextzugriff (PDF)

Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression

Frontiers in oncology, 2022-07, Vol.12, p.917834-917834

2022

Volltextzugriff (PDF)

Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression

Frontiers in oncology, 2021-03, Vol.11, p.642170-642170

2021

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(16)
Animals
(13)
Biological And Medical Sciences
(12)
Female
(11)
Medical Sciences
(11)
Mice
(11)
Immunology
(10)
Oncology
(10)
Microbiology
(9)
Pharmacology. Drug Treatments
(8)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(7)
Male
(7)
Pharmacology & Pharmacy
(7)
Platelets
(7)
Antibiotics
(6)
Antibacterial Agents
(5)
Mice, Inbred Dba
(5)
Microbial Sensitivity Tests
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Activities of the Potent, Broad-Spectrum Carbapenem MK-0826 (L-749,345) against Broad-Spectrum β-Lactamase-and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli Clinical Isolates

In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)

Carbapenems, a new class of beta-lactam antibiotics

Reduced Immunotoxicity and Preservation of Antibacterial Activity in a Releasable Side-Chain Carbapenem Antibiotic

Effects of Antibiotic Therapy on Pseudomonas aeruginosa-Induced Lung Injury in a Rat Model

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime

THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)

In Vivo Evaluation of Three Acid-stable Azalide Compounds, L-701, 677, L-708, 299 and L-708, 365 Compared to Erythromycin, Azithromycin and Clarithromycin

Reduced immunotoxicity and preservation of antibacterial acitivity in a releasable side-chain carbapenem antibiotic

Carbapenems, a new class of beta-lactam antibiotics: Discovery and development of imipenem/cilastatin

Differences in mode of action of (β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy

Thienamycin: development of imipenem-cilastatin

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)

The discovery and synthesis of 2-biphenylcarbapenems active against methicillin resistant staphylococci

Cephamycins, a New Family of β-Lactam Antibiotics. IV. In Vivo Studies

Influence of antibiotic class and concentration on the percentage of release of lipopolysaccharide from Escherichia coli

Beta-lactam antibiotic-induced release of free lipopolysaccharide

Antibacterial Activity of Imipenem: The First Thienamycin Antibiotic

Cephamycins, a New Family of β-Lactam Antibiotics. IV. In Vivo Studies1

Modulation of Immune Responses by Platelet-Derived ADAM10

Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression

Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression

Suchergebnisse filtern